Kira Pharmaceuticals
PrivateLast Round
Series B
Extension
Jan 7, 2021
Total Funding Raised
$71.5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Kira Pharmaceuticals is a biotechnology company that develops complement-targeted therapies to treat immune-mediated diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kira Pharmaceuticals Comparables
Compare Kira Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Apellis Pharmaceuticals | 78% | |
| Q32 Bio | 77% | |
| NovelMed Therapeutics | 77% |
Kira Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jan 7, 2021 | ||||
| Series A | Nov 12, 2020 |
Kira Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series B Extension |
| 健壹资本 | Series A |
| Foresite Capital | Series B Extension |
| 6 Dimensions Capital | Series A |
| APlus Partners | Series B Extension |
| Qiming Venture Partners | Series B Extension, Series A |
| Vivo Capital | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 195% MoM, reaching 3.4K.
- Jul 24, 2026
Monthly visitors grew 5177% MoM, from 22 to 1.2K.
Recent news
Latest coverage and updates
- merges_withJul 17, 2026
Kira Pharma Company merged with Jasper Therapeutics, Inc. on Jul 17th '26.
Kira Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Kira Pharmaceuticals's valuation, stock price, and market status.
Is Kira Pharmaceuticals a public or private company?
Kira Pharmaceuticals is a private company.
What is the current stock price of Kira Pharmaceuticals?
Kira Pharmaceuticals is a private company with no public stock price. No recent secondary market data is available.
How much is Kira Pharmaceuticals worth (valuation)?
Valuation information for Kira Pharmaceuticals is not publicly available.
Can I buy Kira Pharmaceuticals stock?
Kira Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Kira Pharmaceuticals's last funding round?
Kira Pharmaceuticals's most recent funding round was Series B Extension on January 7, 2021.
Who are the main investors in Kira Pharmaceuticals?
Key investors in Kira Pharmaceuticals include RA Capital Management, Qiming Venture Partners, Vivo Capital, Quan Capital.
Will Kira Pharmaceuticals IPO soon?
No public IPO plans have been announced for Kira Pharmaceuticals.
How can I track Kira Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Kira Pharmaceuticals's secondary market activity and sign up for updates.